今开:5.92 | 昨收:6.07 |
最高:6.8 | 最低:5.91 |
涨停价:0.0 | 跌停价:0.0 |
总市值:3.6328138E7 |
Aprea Therapeutics(APRE)03-26 20:25
$Aprea Therapeutics(APRE)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-003887 Act: 34 Size: 6 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-26 19:55
$Aprea Therapeutics(APRE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-003886 Act: 34 Size: 9 MB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 08:55
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034671 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 09:05
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034673 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 08:55
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034672 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-15 08:55
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034670 Size: 10 KB 网页链接查看全文
Aprea Therapeutics(APRE)03-13 04:35
$Aprea Therapeutics(APRE)$ 8-K Current report, items 1.01, 1.02, 3.02, 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-033494 Act: 34 Size: 1 MB 网页链接查看全文
Aprea Therapeutics(APRE)02-14 21:05
$Aprea Therapeutics(APRE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-002595 Act: 34 Size: 41 KB 网页链接查看全文
Aprea Therapeutics(APRE)02-09 19:05
$Aprea Therapeutics(APRE)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-012446 Act: 33 Size: 523 KB 网页链接查看全文
智通财经APP获悉,9月21日(周二)美股开盘,三大指数齐涨。道琼斯指数涨0.38%;纳斯达克综合指数涨0.50%;标普500指数涨0.46%。 个股消息 Aprea Therapeutics(APRE.US)盘初涨2.89%,旗下在研药物1/2期临床试验数据公布。 壳牌(RDS.A.US)... 网页链接
智通财经APP获悉,9月21日(周二)美股盘前,截至北京时间16:35,Aprea Therapeutics(APRE.US)涨18.35%,报5.74美元/股。消息面上,该公司在2021年欧洲肿瘤内科学会年会(ESMO)上,公布了在研药物突变抑制Eprenetapopt用于治疗晚期实体肿... 网页链接
【行情】生物制药公司Aprea Therapeutics(APRE.O)上涨14%,此前美国食品药品监督管理局批准其孤儿药用于白血病治疗。(美港电讯) 生物制药公司Aprea Therapeutics(APRE.O)上涨14%,此前美国食品药品监督管理局批准其孤儿药用于白血病治疗。 网页链接
$Aprea Therapeutics(APRE)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-003887 Act: 34 Size: 6 MB 网页链接
$Aprea Therapeutics(APRE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-003886 Act: 34 Size: 9 MB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034673 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034672 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034671 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-034670 Size: 10 KB 网页链接
$Aprea Therapeutics(APRE)$ 8-K Current report, items 1.01, 1.02, 3.02, 7.01, 8.01, and 9.01 Accession Number: 0001104659-24-033494 Act: 34 Size: 1 MB 网页链接
$Aprea Therapeutics(APRE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-002595 Act: 34 Size: 41 KB 网页链接
$Aprea Therapeutics(APRE)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-012446 Act: 33 Size: 523 KB 网页链接
$Aprea Therapeutics(APRE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-005323 Act: 34 Size: 91 KB 网页链接